Investigational Site Number : 0560003

Yvoir 5530

1 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Thrombotic Thrombocytopenic Purpura

Studies at this site

• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura — Completed